1431 Developing an FDA-qualified drug development tool, the membrane proteome array, for specificity testing of antibodies and CAR-T cell therapies

• Michael Phelan,
• Tabb Sullivan,
• Diana Norden,
• Talia Marano,
• Carmen Navia,
• Rachel Fong,
• Amrita Singh,
• Benjamin Doranz

Affiliations

Michael Phelan

Integral Molecular, Philadelphia, PA, USA

Tabb Sullivan

Integral Molecular, Philadelphia, PA, USA

Diana Norden

Integral Molecular, Philadelphia, PA, USA

Talia Marano

Integral Molecular, Philadelphia, PA, USA

Carmen Navia

Integral Molecular, Philadelphia, PA, USA

Rachel Fong

Integral Molecular, Philadelphia, PA, USA

Amrita Singh

Integral Molecular, Philadelphia, PA, USA

Benjamin Doranz

Integral Molecular, Philadelphia, PA, USA